Описание

Supplementary information from the review of regenerative cellular therapies for non-scarring alopecia.

Figure 5

Source Paper

Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.

Pharmaceutics (2022)

PMID: 35335987

DOI: 10.3390/pharmaceutics14030612

Cite This Figure

![Figure 5: Supplementary information from the review of regenerative cellular therapies for non-scarring alopecia.]()

> Source: Talagavadi Channaiah Anudeep et al. "Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.." *Pharmaceutics*, 2022. PMID: [35335987](https://pubmed.ncbi.nlm.nih.gov/35335987/)

<figure>
  <img src="" alt="Supplementary information from the review of regenerative cellular therapies for non-scarring alopecia." />
  <figcaption>Figure 5. Supplementary information from the review of regenerative cellular therapies for non-scarring alopecia.<br>  Source: Talagavadi Channaiah Anudeep et al. "Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.." <em>Pharmaceutics</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35335987/">35335987</a></figcaption>
</figure>

Связанные доказательства

Minoxidil для Андрогенетическая алопеция

Оценка A · 299 исследований

Finasteride для Андрогенетическая алопеция

Оценка A · 206 исследований

PRP-терапия для Alopecia Areata

Оценка A · 89 исследований

Minoxidil для Alopecia Areata

Оценка A · 122 исследований

PRP-терапия для Андрогенетическая алопеция

Оценка A · 144 исследований